Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Second pivotal phase III trial of lubiprostone in paediatric patients with functional constipation.

Trial Profile

Second pivotal phase III trial of lubiprostone in paediatric patients with functional constipation.

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 14 Mar 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 14 Mar 2014 Initiation of this trial may be affected following findings from an adult chronic idiopathic constipation trial that evaluated the same liquid formulation of lubiprostone as the one to be used in this trial. Safety was not an issue.
    • 24 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top